Home » Newsletters » BioWorld

BioWorld

Dec. 10, 1993

View Archived Issues

BIOTECH-RELATED PATENTS

IMMULOGIC FILES IND FOR ALLERVAX RAGWEED

PROGENICS AWARDED PHASE II SBIR FOR AIDS VACCINE

BRITISH GENE THERAPY COMPANY RAISES $9.6M

CALGENE FILES FOR SHELF OFFERING

SHAMAN UNDERWRITERS EXERCISE OPTION

NAVY ENLISTS BIOMOLECULES TO BATTLE BARNACLES

ARGUS UNDERWRITERS EXERCISE OPTION

HYAL AUSTRALIA FILES FOR $6.7M OFFERING

LEGAL VS. SCIENTIFIC STANDARDS AT ORI

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...